Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for pseudomonas aeruginosa bloodstream infections (shorten-2 trial)

HIGHLIGHTS

• who: Josu00e9 Molina and collaborators from the Unit of Infectious Diseases, Microbiology and Parasitology, Virgen del Rocu0131u0301o University Hospital, Seville, Department of Pharmacy, Virgen del Rocu0131u0301o University Hospital, Seville, Spain have published the research: Study protocol for a randomized clinical trial to assess 7 versus 14-days of treatment for Pseudomonas aeruginosa bloodstream infections (SHORTEN-2 trial), in the Journal: PLOS ONE of 11/Oct/2022
• what: The aim of the trial , as well as its methodology, align well with some of these proposals. The DOOR/RADAR analyses implemented in the trial provides a useful . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.